Advertisement
Screener

SONOMA PHARMACEUTICALS, INC. (SNOA) Income (Loss) from Continuing Operations, Per Basic Share

2.8 / 5 stars · 68/120 Roast Me

SONOMA PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations, Per Basic Share

SONOMA PHARMACEUTICALS, INC. (SNOA) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.31 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.

Discontinued › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2022-02-11

  • SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2021-12-31 was -$0.31.
  • SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2021-09-30 was -$0.04, a 150.00% decline year-over-year.
  • SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2021-06-30 was -$0.52.
  • SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2020-12-31 was -$0.31.
  • SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per basic share for fiscal 2021 was -$2.31.
  • SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per basic share for fiscal 2020 was -$2.42.
Period endIncome (Loss) from Continuing Operations, Per Basic Share 3 monthIncome (Loss) from Continuing Operations, Per Basic Share 3 month as first filedIncome (Loss) from Continuing Operations, Per Basic Share 6 monthIncome (Loss) from Continuing Operations, Per Basic Share 9 monthIncome (Loss) from Continuing Operations, Per Basic Share 12 month
2021-12-31-$0.31
10-Q · filed 2022-02-11
-$0.85
10-Q · filed 2022-02-11
2021-09-30-$0.04
10-Q · filed 2021-11-15
-$0.54
10-Q · filed 2021-11-15
2021-06-30-$0.52
10-Q · filed 2021-08-16
2021-03-31-$2.31
10-K · filed 2021-07-14
2020-12-31-$0.31
10-Q · filed 2022-02-11
-$0.60
10-Q · filed 2022-02-11
2020-09-30$0.08
10-Q · filed 2021-11-15
-$0.29
10-Q · filed 2021-11-15
2020-06-30-$0.39
10-Q · filed 2021-08-16
$0.02
10-Q · filed 2020-08-14
2020-03-31-$2.42
10-K · filed 2021-07-14
2019-12-31-$0.81
10-Q · filed 2021-02-16
-$1.32
10-Q · filed 2021-02-16
2019-09-30-$0.98
10-Q · filed 2020-11-20
-$0.47
10-Q · filed 2020-11-20
2019-06-30$0.51
10-Q/A · filed 2020-11-17
$0.40
10-Q · filed 2020-08-14
2017-12-31-$0.73
10-Q · filed 2018-02-14
-$2.21
10-Q · filed 2018-02-14
2017-09-30-$0.67
10-Q · filed 2017-11-14
-$1.48
10-Q · filed 2017-11-14
2017-06-30-$0.82
10-Q · filed 2017-08-08
2016-12-31$0.18
10-Q · filed 2018-02-14
-$1.36
10-Q · filed 2018-02-14
2016-09-30-$0.63
10-Q · filed 2017-11-14
-$1.39
10-Q · filed 2017-11-14
2016-06-30-$0.76
10-Q · filed 2017-08-08
2015-12-31-$1.28
10-Q · filed 2017-02-17
-$3.46
10-Q · filed 2017-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26